Susquehanna International Group’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Buy |
43,332
+25,114
| +138% | +$173K | ﹤0.01% | 5041 |
|
|
2025
Q1 | $96.7K | Sell |
18,218
-11,596
| -39% | -$61.6K | ﹤0.01% | 5868 |
|
|
2024
Q4 | $352K | Sell |
29,814
-996
| -3% | -$11.8K | ﹤0.01% | 4540 |
|
|
2024
Q3 | $636K | Buy |
30,810
+24,972
| +428% | +$515K | ﹤0.01% | 3310 |
|
|
2024
Q2 | $264K | Buy |
+5,838
| New | +$264K | ﹤0.01% | 4370 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5719 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6033 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5674 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5775 |
|
|
2023
Q1 | – | Sell |
-5,247
| Closed | -$17.4K | – | 6075 |
|
|
2022
Q4 | $17.4K | Buy |
5,247
+2,138
| +69% | +$7.09K | ﹤0.01% | 5388 |
|
|
2022
Q3 | $15K | Sell |
3,109
-117
| -4% | -$564 | ﹤0.01% | 5775 |
|
|
2022
Q2 | $24K | Sell |
3,226
-19,727
| -86% | -$147K | ﹤0.01% | 5386 |
|
|
2022
Q1 | $366K | Sell |
22,953
-17,988
| -44% | -$287K | ﹤0.01% | 4102 |
|
|
2021
Q4 | $756K | Buy |
40,941
+10,169
| +33% | +$188K | ﹤0.01% | 3226 |
|
|
2021
Q3 | $942K | Buy |
30,772
+8,240
| +37% | +$252K | ﹤0.01% | 2840 |
|
|
2021
Q2 | $1.24M | Sell |
22,532
-16,393
| -42% | -$900K | ﹤0.01% | 2695 |
|
|
2021
Q1 | $2.3M | Buy |
38,925
+17,033
| +78% | +$1.01M | ﹤0.01% | 1961 |
|
|
2020
Q4 | $821K | Sell |
21,892
-307
| -1% | -$11.5K | ﹤0.01% | 2828 |
|
|
2020
Q3 | $1.2M | Buy |
22,199
+21,114
| +1,946% | +$1.14M | ﹤0.01% | 1980 |
|
|
2020
Q2 | $273K | Sell |
1,085
-5,556
| -84% | -$1.4M | ﹤0.01% | 3455 |
|
|
2020
Q1 | $1.04M | Sell |
6,641
-4,037
| -38% | -$635K | ﹤0.01% | 1987 |
|
|
2019
Q4 | $1.75M | Buy |
10,678
+9,787
| +1,098% | +$1.6M | ﹤0.01% | 1475 |
|
|
2019
Q3 | $130K | Sell |
891
-6,186
| -87% | -$903K | ﹤0.01% | 4008 |
|
|
2019
Q2 | $1.47M | Buy |
7,077
+2,756
| +64% | +$573K | ﹤0.01% | 1591 |
|
|
2019
Q1 | $901K | Buy |
4,321
+2,790
| +182% | +$582K | ﹤0.01% | 1398 |
|
|
2018
Q4 | $268K | Buy |
1,531
+261
| +21% | +$45.7K | ﹤0.01% | 2676 |
|
|
2018
Q3 | $288K | Sell |
1,270
-1,015
| -44% | -$230K | ﹤0.01% | 2461 |
|
|
2018
Q2 | $346K | Sell |
2,285
-3,371
| -60% | -$510K | ﹤0.01% | 2576 |
|
|
2018
Q1 | $1.04M | Buy |
5,656
+287
| +5% | +$52.5K | ﹤0.01% | 1452 |
|
|
2017
Q4 | $1.14M | Buy |
+5,369
| New | +$1.14M | ﹤0.01% | 1648 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 3321 |
|
|
2017
Q2 | – | Sell |
-10,291
| Closed | -$2.55M | – | 3640 |
|
|
2017
Q1 | $2.55M | Buy |
10,291
+9,540
| +1,270% | +$2.36M | ﹤0.01% | 844 |
|
|
2016
Q4 | $190K | Sell |
751
-2,881
| -79% | -$729K | ﹤0.01% | 3728 |
|
|
2016
Q3 | $740K | Buy |
+3,632
| New | +$740K | ﹤0.01% | 1664 |
|